Lewis Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Lewis Asset Management's PFE Position: Q3 2026 in Review
Lewis Asset Management reduced its Pfizer (PFE) stake by 3.9% in Q3 2026, selling an estimated $18.5K and leaving 17,230 shares worth $491K. The position accounts for 0.17% of the portfolio, ranked #128.
Lewis Asset Management first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $950K in Q3 2024. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Lewis Asset Management held 17,230 shares of Pfizer worth $491K as of Q3 2026.
- Lewis Asset Management sold 697 Pfizer shares in Q3 2026, an estimated $18.5K.
- Pfizer made up 0.17% of Lewis Asset Management's portfolio in Q3 2026, its #128 holding.
- Lewis Asset Management first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
- Lewis Asset Management's Pfizer position peaked at $950K in Q3 2024.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Lewis Asset Management's 13F filing for Q3 2026, filed 14 Oct 2026.